Pharma & Life Sciences

FDA to Participate in Covid-19 Diagnostics Evidence Accelerator

June 18, 2020, 2:59 PM

The FDA will participate in the Covid-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research.

  • The accelerator will allow experts in health data to analyze diagnostic and clinical data in real time
  • The accelerator will observe Covid-19 diagnostic tests and antibody tests and how they are best used to tailor testing strategies to specific populations
  • “This collaboration with the FDA, scientists and data experts is meeting the urgency of the moment to speed the pace of diagnostic testing,”Ellen Sigal, Chair of both the...

To read the full article log in. To learn more about a subscription click here.